Qiagen NV said Tuesday it will receive kits for a molecular test for HIV-1 in a deal with Abbott Laboratories. Financial details of the deal were not disclosed.
Inside these posts: Tests
Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Tainted beef raises prospects of new testing
The first outbreak linked to a rare strain of E. coli in ground beef is prompting a fresh look at tougher regulations to protect the nation’s meat supply. Get the full story »
Abbott gets OK for gonorrhea/chlamydia test
Abbott Laboratories said Monday that the Food and Drug Administration approved a new diagnostic test that allows for the detection of two sexually transmitted diseases.
Abbott’s RealTime Chlamydia trachomatis/neisseria gonorrhoeae (CT/NG) assay and Abbott’s m2000 System can detect gonorrhea and chlamydia, a disease that often goes untreated because of its lack of symptoms. Get the full story »
